Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 8 hrs 47 mins

S&P Futures
4,140.75
-6.00(-0.14%)
Dow Futures
32,726.00
-31.00(-0.09%)
Nasdaq Futures
13,221.75
-7.00(-0.05%)
Russell 2000 Futures
1,919.20
-2.60(-0.14%)
Crude Oil
89.26
+0.25(+0.28%)
Gold
1,788.10
-3.10(-0.17%)

Advertisement

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

4.6800

+0.1500

(+3.31%)

At close: 04:00PM EDT

4.3200

-0.36

(-7.69%)

After hours:

07:51PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	4.5300
Open	4.4200
Bid	0.0000 x 4000
Ask	0.0000 x 1800
Day's Range	4.2200 - 4.7900
52 Week Range	4.0000 - 14.7300
Volume	2,658,497
Avg. Volume	2,404,091

Market Cap	353.562M
Beta (5Y Monthly)	0.04
PE Ratio (TTM)	N/A
EPS (TTM)	-2.7600
Earnings Date	May 02, 2022 - May 06, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	12.50

All

Motley Fool
Why Karyopharm Therapeutics Inched Higher Today
The company's second-quarter performance had some highlights, but investors might have been concerned about full-year guidance.
Simply Wall St.
Shareholders in Karyopharm Therapeutics (NASDAQ:KPTI) are in the red if they invested three years ago
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
Motley Fool
Karyopharm Therapeutics (KPTI) Q2 2022 Earnings Call Transcript
Today, I'm joined by Richard Paulson, president and chief executive officer; Sohanya Cheng, chief commercial officer; Dr. Reshma Rangwala, chief medical officer; and Mr. Mike Mason, chief financial officer. Earlier this morning, we issued a press release detailing Karyopharm's financial results for the second quarter 2022.

Advertisement

S&P Futures4,140.75-6.00(-0.14%)

Dow Futures32,726.00-31.00(-0.09%)

Nasdaq Futures13,221.75-7.00(-0.05%)

Russell 2000 Futures1,919.20-2.60(-0.14%)

Crude Oil89.26+0.25(+0.28%)

Gold1,788.10-3.10(-0.17%)

Karyopharm Therapeutics Inc. (KPTI)

Chart Events

Performance Outlook

Why Karyopharm Therapeutics Inched Higher Today

Shareholders in Karyopharm Therapeutics (NASDAQ:KPTI) are in the red if they invested three years ago

Karyopharm Therapeutics (KPTI) Q2 2022 Earnings Call Transcript

S&P Futures
4,140.75
-6.00(-0.14%)

Dow Futures
32,726.00
-31.00(-0.09%)

Nasdaq Futures
13,221.75
-7.00(-0.05%)

Russell 2000 Futures
1,919.20
-2.60(-0.14%)

Crude Oil
89.26
+0.25(+0.28%)

Gold
1,788.10
-3.10(-0.17%)